South Africa

Resilience System

Main menu


You are here

Home › RSV vaccine: Moderna, Pfizer’s race to obtain FDA approval process › RSV vaccine: Moderna, Pfizer’s race to obtain FDA approval process

RSV vaccine: Moderna, Pfizer’s race to obtain FDA approval process

Primary tabs

RSV vaccine: Moderna, Pfizer’s race to obtain FDA approval process

Thu, 2023-01-19 00:32 — mike kraft

Moderna, Pfizer’s new race: The RSV vaccine FDA approval process

...

Pfizer’s vaccine is already in the FDA approval process and Moderna CEO Stéphane Bancel told CNBC from Davos on Wednesday that it will be filing for FDA approval for its vaccine soon — it even had a plan in place for top executives to be ready to submit over the holidays if needed.

ALSO SEE: Moderna says its RNA vaccine was nearly 84% effective in preventing symptoms in adults 60 and older

 

...

 

 

Country / Region Tags: 
Germany
Global
United States
General Topic Tags: 
Seasonal Flu
Disease
Disease Prevention
Government
Health
Medical Testing
Mutations
Pandemics
Policy
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Groups this Group Post belongs to: 
- Private group -
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks
Page loaded in 1.752 seconds.